Predicting treatment response to mandibular advancement therapy using a titratable thermoplastic device

Wojciech Trzepizur1,2,3, Benjamin Adrian4, Marc Le Vaillant5

  • 1INSERM U1063, SOPAM, Angers University, F-49045, Angers, France. wotrzepizur@chu-angers.fr.

Summary

A trial with a thermoplastic mandibular advancement device (MAD) can predict the success of custom-made MADs for obstructive sleep apnea (OSA). This method shows promise for identifying effective treatments for OSA patients.

Related Concept Videos